AscendiantLogo Better
Contact

Ascendiant Capital Markets, LLC

Ascendiant News

See Our Impact

Need capital to meet your growth plans? Get in touch with our team today!

Ascendiant Serves as Financial Advisor on $25,200,000 Registered Direct for Atossa Therapeutics, Inc. (NasdaqCM: ATOS)

JUPITER, Florida — January 8, 2021 — Ascendiant Capital Markets, LLC (“Ascendiant”) announced today the closing of a $25,200,000 Registered Direct for Atossa Therapeutics, Inc. (NasdaqCM: ATOS) of Seattle, Washington.  For a copy of the announcement, please click here.

Share this post with your friends:

Facebook
Twitter
LinkedIn

Want to stay up-to-date with the latest at Ascendiant? Subscribe to our mailing list!

Newsletter Form (#2)

See other recent news

June 30, 2025
Ascendiant Initiates Equity Research Coverage on Aytu BioPharma, Inc. (Nasdaq: AYTU)
June 10, 2025
Ascendiant Capital Markets LLC Serves as Financial Advisor on $16,600,000 Public Offering for Aytu BioPharma, Inc. (Nasdaq: AYTU)
April 30, 2025
Ascendiant Capital Markets LLC Serves as Financial Advisor on $5,000,000 Private Placement for Verb Technology Company, Inc. (Nasdaq: VERB)
April 21, 2025
Ascendiant Capital Markets LLC Serves as Sole Sales Agent on $8,850,000 At-the-Market (ATM) Offering for Duos Technologies Group, Inc. (Nasdaq: DUOT)
February 24, 2025
Ascendiant Capital Markets LLC Serves as Sole Placement Agent on $3,300,000 Private Placement Financing for Sonim Technologies, Inc. (Nasdaq: SONM)
February 18, 2025
Ascendiant Capital Markets LLC Serves as Sole Sales Agent on $3,371,000 At-the-Market (ATM) Offering for Society Pass Incorporated (Nasdaq: SOPA)
January 31, 2025
Ascendiant Capital Markets LLC Serves as Financial Advisor on $7,500,000 Registered Direct for Intrusion Inc. (Nasdaq: INTZ)
January 23, 2025
Ascendiant Hosts IGC Pharma, Inc. (NYSE American: IGC) Fireside Chat 2025
January 10, 2025
Ascendiant Capital Markets LLC to Attend JPM Week in San Francisco, January 13-15, 2025
October 28, 2024
Ascendiant Capital Markets LLC Serves as Sole Sales Agent on $21,340,000 At-the-Market (ATM) Offering for Giftify, Inc. (Nasdaq: GIFT)
October 10, 2024
Ascendiant Initiates Equity Research Coverage on GRI Bio, Inc. (Nasdaq: GRI)
October 7, 2024
Ascendiant Capital Markets LLC Serves as Sole Sales Agent on $6,500,000 At-the-Market (ATM) Offering for Alzamend Neuro, Inc. (Nasdaq: ALZN)

Big enough to deliver

but small enough to care

get in touch
Ascendiant LogoWhite

Services

Resources

Quicklinks

Contact

  • Ascendiant Capital Markets, LLC
Linkedin-in

Important Legal Information & Disclosures

©2025 Ascendiant Capital Markets, LLC, All Rights Reserved.

Member FINRA & SIPC.

a man wearing a suit and tie

Hi there!

How can we help?